Login to Your Account



Vtesse advances pivotal trial for ultra-rare NPC

By Michael Fitzhugh
Staff Writer

Wednesday, October 5, 2016

Vtesse Inc. has notched new progress toward full enrollment of a pivotal trial of its experimental Niemann-Pick type C1 therapy, VTS-270, dosing its first patient in Germany.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription